OraSure HIV Test Has Risks of False Results, FDA Says

People who use what could be the first completely at-home HIV test under development by OraSure Technologies Inc. risk receiving false results, U.S. regulators said in a report.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.